Appendix Table 2.
Variable | Almost Entirely Fatty |
Scattered Fibroglandular Densities |
Heterogeneously Dense |
Extremely Dense |
Overall |
---|---|---|---|---|---|
Recent breast density measure* | |||||
Clinical BI-RADS density | |||||
Interval cancer cases | 5 | 27 | 60 | 26 | 118 |
Screen-detected cancer cases | 54 | 244 | 190 | 40 | 528 |
Sensitivity (95% CI), % | 92 (84–99) | 90(86–94) | 76(71–81) | 61 (49–72) | 82 (79–85) |
Automated BI-RADS density† | |||||
Interval cancer cases | 8 | 23 | 48 | 39 | 118 |
Screen-detected cancer cases | 131 | 191 | 153 | 53 | 528 |
Sensitivity (95% CI), % | 94 (90–98) | 89 (85–93) | 76 (70–82) | 58 (48–68) | 82 (79–85) |
Distant breast density measure‡ | |||||
Clinical BI-RADS density | |||||
Interval cancer cases | 4 | 23 | 62 | 29 | 118 |
Screen-detected cancer cases | 65 | 225 | 188 | 50 | 528 |
Sensitivity (95% CI), % | 94(89–100) | 91 (87–94) | 75(70–81) | 63 (53–74) | 82 (79–85) |
Automated BI-RADS density† | |||||
Interval cancer cases | 6 | 26 | 39 | 47 | 118 |
Screen-detected cancer cases | 118 | 192 | 151 | 67 | 528 |
Sensitivity (95% CI), % | 95 (91–99) | 88 (84–92) | 79 (74–85) | 59 (50–68) | 82 (79–85) |
BI-RADS = Breast Imaging Reporting and Data System.
Defined as >6 mo to <2 y before cancer diagnosis.
Measured with Volpara software.
Defined as 2–5 y before cancer diagnosis.